Physician attitudes about genetic testing for localized prostate cancer: A national survey of radiation oncologists and urologists
Simon P. Kim(Northwestern University), Nilay D. Shah(Mayo Clinic), Stephen B. Williams(Cedars-Sinai Medical Center), Robert Abouassaly(Cleveland Clinic), Jon C. Tilburt(Mayo Clinic in Florida), Badrinath R. Konety(Allina Health), Cary P. Gross(Yale Cancer Center), Christopher Weight, James B. Yu(Harvard University), Neal J. Meropol(Flatiron Health (United States))
Urologic Oncology Seminars and Original Investigations
September 3, 2018
Cited by 7
Related Papers
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
|Journal of Clinical Oncology|2015|903
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804